News

News

Trump drug pricing plan could cost industry £800bn

07 May 2025


Bloomberg reported on 7 May that the pharmaceutical industry is mounting a fierce campaign against a new drug pricing proposal from President Donald Trump's administration. The plan, proposed as a potential method to help fund the president's tax cut agenda, could slash drug company revenues by as much as $1 trillion (£800bn) over the next decade.

 

 

[BACK TO NEWS]